Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography
about
A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.Cholesterol in the retina: the best is yet to come.An in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMDAssociations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular healthLow-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trialDelayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.A false color fusion strategy for drusen and geographic atrophy visualization in optical coherence tomography imagesChange in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imagingEffects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study.Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population.Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study.Disappearance of soft drusen and subsequent development of choroidal neovascularization following macular hole surgery: a case reportIn-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging.Drusen and photoreceptor abnormalities in African-Americans with intermediate non-neovascular age-related macular degenerationIdentification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography.DYNAMISM OF DOT SUBRETINAL DRUSENOID DEPOSITS IN AGE-RELATED MACULAR DEGENERATION DEMONSTRATED WITH ADAPTIVE OPTICS IMAGING.Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imagingDrusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration.Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.Optical coherence tomography-based correlation between choroidal thickness and drusen load in dry age-related macular degeneration.Drusen volume development over time and its relevance to the course of age-related macular degeneration.Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration.Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.Activated Retinal Pigment Epithelium, an Optical Coherence Tomography Biomarker for Progression in Age-Related Macular Degeneration.Algorithms for the Automated Analysis of Age-Related Macular Degeneration Biomarkers on Optical Coherence Tomography: A Systematic Review.In Vivo Multimodal Imaging of Drusenoid Lesions in Rhesus Macaques.Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.Developing prognostic biomarkers in intermediate age-related macular degeneration: their clinical use in predicting progression.
P2860
Q30240689-4E11B6DD-58A2-4546-B7FC-AAE06C87CDC0Q33758267-24F10BF9-609E-46CC-A7B7-E35208F7AAC7Q33867675-6DD54B52-2DBD-4D6C-81C4-04B961FDA7D2Q34003267-BA331D38-DB18-409A-BEE8-FEEE1E30A9FFQ34486375-99508F01-257E-4291-8336-0729C2953450Q34500095-7BD90CEF-7289-47A5-870B-E3968CCCACC9Q34543657-60BB9489-4119-491A-B9F6-ACBCC44C1950Q34575838-87848491-1B8B-48A9-A259-2068199BAA67Q34646906-930385E0-384F-49A4-8EA5-E810B6128D67Q35088759-716A715A-ABE9-4189-98C2-97BD3FA8D1D1Q35482225-C5E81474-A5BA-489A-AC98-35A11C88C9F5Q35583826-6336E96B-CC0F-43C1-9714-40B580D8A4BDQ35612233-57CF6173-CBF3-4711-84D8-42FA6FE6F0BDQ35809866-0152DE93-42F1-405A-A1AB-74DA57C6147CQ35897928-1E7B14F9-C01C-4048-95E7-AD59A1790596Q36279801-34C8A50F-8539-4B9E-9C88-9C4460788172Q36508205-0A97C132-CE03-4B20-B8B6-8029486E80C7Q36754160-6B28883B-0165-45DD-B19A-B0ED8A8E3BAAQ36758308-8DA2F000-5039-489F-A47E-893FD8A6F1D8Q37107078-D70B73DA-6B92-475F-BFC4-C79FAFAC8E38Q37513827-F44CB662-933C-4C03-8D68-1527A55FCBE0Q37626354-7A71FF7F-A2D7-4A43-B6CD-258372ABB99AQ37627216-1E847987-2841-42B4-970B-A8B8D31F859DQ37684465-23D65186-9C65-4E68-8C1E-4C3B07D56075Q38605292-7B7BFD37-835C-4547-9E93-7A8B94B8EB31Q38635651-809F16D8-03E5-4667-9BCE-834C4063D6B6Q38668952-267D7932-718F-4353-8212-553EEFBABD96Q43669289-3F8E8206-2E33-477D-952A-ED5BA59A88BCQ44984005-685B6FE6-BC9C-41D8-A9AD-7AFB53918CB3Q50025127-6161B4A1-3E5F-4E46-BE24-6B8A55BF620D
P2860
Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Natural history of drusen morp ...... n optical coherence tomography
@ast
Natural history of drusen morp ...... n optical coherence tomography
@en
type
label
Natural history of drusen morp ...... n optical coherence tomography
@ast
Natural history of drusen morp ...... n optical coherence tomography
@en
prefLabel
Natural history of drusen morp ...... n optical coherence tomography
@ast
Natural history of drusen morp ...... n optical coherence tomography
@en
P2093
P2860
P1433
P1476
Natural history of drusen morp ...... n optical coherence tomography
@en
P2093
Fenghua Wang
Giovanni Gregori
Philip J Rosenfeld
William J Feuer
Zohar Yehoshua
P2860
P304
P356
10.1016/J.OPHTHA.2011.05.008
P577
2011-07-02T00:00:00Z